In recent years, the pharmaceutical business has faced unprecedented challenges. The previous three years have seen a 24% increase in the average cost of pharmaceuticals in the United States due to safety concerns, issues with specific prescriptions, and competition from both non-generic and generic medications. Prescription costs for those with private insurance decreased by 4% as a result between 2010 and 2013.Developing nations like China, India, and Brazil have comparable difficulties. Creating a series of vaccines with medicinal qualities is one such intervention.In order to treat bacterial illnesses and maintain population and individual health over the long term, antibiotics are required. However, bacterial diseases resistant to antibiotics pose a threat to international health.